ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,974Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 2588

$995K Total Retail Price of All Prescriptions

Rank: 90 out of 2588

561 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

12% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 14,223 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
WARFARIN SODIUM 653 626 1 10
LEVOTHYROXINE SODIUM 556 510 2 2
LISINOPRIL 483 420 3 3
PRAVASTATIN SODIUM 447 390 4 16
OMEPRAZOLE 423 394 5 6
AMLODIPINE BESYLATE 387 346 6 4
SIMVASTATIN 347 324 7 1
FUROSEMIDE 316 293 8 5
HYDROCODONE-ACETAMINOPHEN 261 221 S3 9 7
METOPROLOL SUCCINATE 260 236 10 12
METOPROLOL TARTRATE 255 233 11 9
ATORVASTATIN CALCIUM 246 223 12 11
CARVEDILOL 244 212 13 20
GABAPENTIN 214 194 14 18
METFORMIN HCL 213 171 15 8
TRAMADOL HCL 209 193 16 19
PREDNISONE 189 165 17 42
HYDROCHLOROTHIAZIDE 187 172 18 13
ZOLPIDEM TARTRATE 184 171 19 24
METFORMIN HCL ER 174 149 20 67
TAMSULOSIN HCL 168 160 21 23
LOSARTAN POTASSIUM 165 146 22 17
CITALOPRAM HBR 148 147 23 27
FAMOTIDINE 145 137 24 36
CYMBALTA 141 122 25 70
MIRTAZAPINE 137 137 26 63
CLOPIDOGREL 136 119 27 30
GLIPIZIDE 131 110 28 44
ATENOLOL 130 97 29 14
BUMETANIDE 129 120 30 117
ROPINIROLE HCL 127 122 31 113
IPRATROPIUM-ALBUTEROL 121 121 32 104
DIGOXIN 120 114 33 38
TIZANIDINE HCL 113 89 34 225
SPIRONOLACTONE 112 108 35 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 88 36 35
POTASSIUM CHLORIDE 107 92 37 15
POLYETHYLENE GLYCOL 3350 105 92 38 55
ALLOPURINOL 105 95 38 33
LANTUS SOLOSTAR 103 95 40 93
SERTRALINE HCL 100 99 41 26
AZITHROMYCIN 97 84 42 45
DONEPEZIL HCL 97 97 42 22
PLAVIX 96 86 44 43
DIOVAN 94 93 45 29
LYRICA 91 61 46 100
ISOSORBIDE MONONITRATE ER 89 82 47 49
LEVETIRACETAM 87 83 48 90
CRESTOR 85 58 49 25
KLOR-CON M20 84 82 50 52
BACLOFEN 84 84 50 142
DILTIAZEM HCL 82 76 52 228
CEFDINIR 81 66 53 358
NIFEDIPINE ER 80 66 54 59
GLYBURIDE 80 68 R 54 65
TRIAMCINOLONE ACETONIDE 78 67 56 106
CARBIDOPA-LEVODOPA 77 77 57 83
PAROXETINE HCL 77 61 57 71
ADVAIR DISKUS 74 60 59 48
NAMENDA 73 73 60 32
DOXAZOSIN MESYLATE 71 62 61 96
TRIAMTERENE-HCTZ 70 66 62 46
CLONIDINE HCL 70 67 62 54
LEVOFLOXACIN 69 56 64 77
ALENDRONATE SODIUM 67 67 65 21
DILTIAZEM 24HR CD 65 65 66 98
LOVASTATIN 64 41 67 34
METHYLPREDNISOLONE 63 53 68 144
PROAIR HFA 61 39 69 50
CIPROFLOXACIN HCL 59 49 70 82
JANUVIA 59 50 70 60
TERAZOSIN HCL 58 58 72 137
PANTOPRAZOLE SODIUM 57 56 73 28
PEN NEEDLE 57 46 73 112
QUETIAPINE FUMARATE 57 57 73 74
ZETIA 55 43 76 69
FINASTERIDE 54 54 77 97
SPIRIVA 54 41 77 56
MELOXICAM 53 46 79 51
CYCLOBENZAPRINE HCL 53 27 R 79 87
HUMALOG 52 39 81 141
DOXYCYCLINE HYCLATE 51 46 82 151
TOPIRAMATE 50 32 83 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.